Menu

Meet the New HHMI Crop

The Howard Hughes Medical Institute has tapped 27 biomedical researchers for their scientific excellence.

May 9, 2013
Bob Grant

WIKIMEDIA, StFXTwenty-seven US scientists will join the prestigious ranks of existing Howard Hughes Medical Institute (HHMI) researchers, with today’s (May 9) announcement of the awardees. Hailing from 19 institutions across the country, the researchers score a 5-year appointment that will pay their full salary, benefits, and a substantial research and equipment budget over that time. “HHMI has a very simple mission,” said HHMI President Robert Tjian in a statement. “We find the best original-thinking scientists and give them the resources to follow their instincts in discovering basic biological processes that may one day lead to better medical outcomes. This is a very talented group of scientists. And while we cannot predict where their research will take them, we’re eager to help them move science forward.”

The list of new HHMI researchers includes:

Peter Baumann, Stowers Institute for Medical Research, who studies telomerase and asexual reproduction in a unisexual whiptail lizard species

Michael Brainard, University of California, San Francisco, who studies the neurophysiological underpinnings of song learning in birds

Karl Deisseroth, Stanford University, an optogenetics pioneer

Peter Reddien, Massachusetts Institute of Technology, who studies regeneration in planaria

Rachel Wilson, Harvard Medical School, who studies sensory processing in Drosophila

Yukiko Yamashita, University of Michigan, who studies the intricacies of stem cell differentiation

Check out the full list of HHMI awardees at the HHMI website.

Correction (May 9): The original version of this article referred to the arrangement enjoyed by HHMI Investigators as a "grant." In fact, these positions are appointments, with HHMI Investigators essentially becoming employees of the Institute. The correction has been made, and The Scientist regrets the error.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.